Abstract

e15116 Background: Despite heightened awareness of risks from ionizing radiation, the use of image-guided therapy is rising. Our goal was to calculate the radiation effective dose (ED) received during computed tomography (CT)-guided percutaneous cryoablation (PC) of renal masses. Methods: A retrospective chart review from January 2008 to June 2009 found 21 patients had undergone CT-guided PC. Using radiation dose estimates from the procedures based on a standard anthropomorphic phantom, mean radiation ED was estimated. Fluoroscopy time and total ED were used to compute the learning curve which was assessed with correlation testing. Results: We performed PC on 24 masses ranging from 0.9-8.0cm. Mean patient age, body mass index, and lesion size were 65.8 years, 28.3, and 2.9 cm, respectively. For each mass ablated, mean fluoroscopy time was 46.4 seconds (range 11.4-143.4 sec), mean fluoroscopy ED was 8.2 mSv (range 1.9-28.0 mSv), and mean total ED was 21.6 mSv (range 10.1-37.5 mSv). We estimated the learning curve by dividing the 24 masses into quartiles and calculated the mean mass size, fluoroscopy time, and total ED per quartile. There was a 59.3% decrease in fluoroscopy time and a 39.4% decrease in total ED between the 1st and 4th quartile despite a 17.7% increase in mass size. Fluoroscopy time was moderately correlated with case number (R2=0.32). When plotting fluoroscopy time utilized per individual mass versus case number a decline was seen (R2=0.35). Fluoroscopy time alone was minimally correlated with mass size (R2=0.19) and not at all with BMI (R2=0.05). Conclusions: Fluoroscopy time declined as operator experience increased, subjecting patients to less radiation exposure. Mean total radiation ED was 21.6 mSv for all cases. For comparison, three-phase renal CT ED on our scanner was 23.7 mSv. While the greatest decline in fluoroscopy time (51.0%) occurred between the 1st and 2nd quartile, there was still an 11.0% time decrease between the 3rd and 4th quartile suggesting continued improvement in the learning curve. No significant financial relationships to disclose.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.